HomeOrderingContact UsAbout UsInvestor InformationSite Map

Press Releases

Archived Press Releases

For information regarding press releases please contact us at:
Phone: (402) 452-5437
Fax: (402) 452-5461
E-mail: investorrelations@transgenomic.com

Disclaimer

The following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued. Investors should not assume that statements made in these documents remain accurate and complete as of any later date.

Such statements were and remain subject to certain factors, risks and uncertainties, including those described in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties could have caused the actual results, events and performance to differ materially from those referred to in such statements.

Transgenomic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any of these documents to reflect any change in Transgenomic's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements were based.

Available Archives
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
2008 Archive
December 9, 2008ViewTransgenomic Receives Accreditation from College of American Pathologists
 
December 4, 2008ViewTransgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology
 
December 2, 2008ViewTransgenomic Signs Letter of Intent for an Agreement to Exclusive License with Option to Acquire Power3 Medical Products’ Neurodegenerative Diagnostics
 
November 20, 2008ViewTransgenomic Awarded SBIR Grant to Support Development of SURVEYOR® Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
 
November 6, 2008ViewTransgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference
 
October 29, 2008ViewTransgenomic, Inc. Reports Third Quarter 2008 Results
 
October 29, 2008ViewReminder - Webcast Alert: Transgenomic Inc. Announces Third Quarter 2008 Earnings Release Conference Call Webcast
 
October 22, 2008ViewTransgenomic Inc. Announces Third Quarter 2008 Earnings Release Conference Call Webcast
 
September 16, 2008ViewTransgenomic Announces Partnership with Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
 
August 5, 2008ViewTransgenomic Reports Second Quarter 2008 Results
 
August 5, 2008ViewReminder - Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
 
July 30, 2008ViewTransgenomic Announces 2nd Qtr 2008 Earnings Release Call
 
June 24, 2008ViewHoping to Cut Reseq Costs
 
June 17, 2008ViewTransgenomic Introduces SURVEYOR® Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
 
May 7, 2008ViewTransgenomic, Inc. Reports First Quarter 2008 Results
 
May 7, 2008ViewReminder - Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
 
April 30, 2008ViewTransgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
 
April 22, 2008ViewWebcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
 
March 31, 2008ViewTransgenomic Opens Pharmacogenomics Laboratory in China
 
March 5, 2008ViewTransgenomic Announces New Contracts for Phase II Trials with Two Major Pharmaceutical Companies
 
February 28, 2008ViewTransgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2007 Results
 
February 28, 2008ViewReminder-Webcast Alert Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
 
February 22, 2008ViewWebcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
 
February 5, 2008ViewTransgenomic Appoints David Pauluzzi to Board of Directors
 
January 23, 2008ViewTransgenomic Appoints Dr. Eric Kaldjian as Chief Scientific Officer
 
January 17, 2008ViewSAB Press Release
 
Press Releases
 
Contact WebmasterSend Page To ColleaguePrintable PageChange Country United States
Copyright © 1997-2010 Transgenomic, Inc., All Rights Reserved.the power of discovery™